Fatal Measles Virus Infection After Rituximab-Containing Chemotherapy in a Previously Vaccinated Patient

Authors :: Hansjakob Furrer
Alexander Pöllinger
Philipp Jent
Rupert Langer
Charles Béguelin
Manuel Frey
Sabina Berezowska
Mafalda Trippel
Source :: Jent, Philipp; Trippel, Mafalda; Frey, Manuel; Pöllinger, Alexander; Berezowska, Sabina; Langer, Rupert; Furrer, Hansjakob; Béguelin, Charles Antoine (2018). Fatal Measles Virus Infection After Rituximab-Containing Chemotherapy in a Previously Vaccinated Patient. Open Forum Infectious Diseases, 5(11), ofy244. Oxford University Press 10.1093/ofid/ofy244 , Open Forum Infectious Diseases
Publication Year :: 2018
Publisher :: Oxford University Press, 2018.
Abstract: We report the case of a young patient treated with rituximab-containing chemotherapy who was infected with measles despite previous vaccination. Treatment with vitamin A, ribavirin, and immunoglobulins was started; nevertheless he developed severe pneumonitis and deceased. Broad vaccination coverage is crucial in protecting vulnerable subjects.

Language :: English
Database :: OpenAIRE
Journal :: Jent, Philipp; Trippel, Mafalda; Frey, Manuel; Pöllinger, Alexander; Berezowska, Sabina; Langer, Rupert; Furrer, Hansjakob; Béguelin, Charles Antoine (2018). Fatal Measles Virus Infection After Rituximab-Containing Chemotherapy in a Previously Vaccinated Patient. Open Forum Infectious Diseases, 5(11), ofy244. Oxford University Press 10.1093/ofid/ofy244 <http://dx.doi.org/10.1093/ofid/ofy244>, Open Forum Infectious Diseases
Accession number :: edsair.doi.dedup.....94ea89a50446fd6e546e1e264dbd0dad
Full Text :: https://doi.org/10.7892/boris.121127

Full Text Access

Tools